Weekly docetaxel versus CMF as adjuvant chemotherapy for elderly breast cancer patients: safety data from the multicentre phase 3 randomised ELDA trial (Q31141377)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Weekly docetaxel versus CMF as adjuvant chemotherapy for elderly breast cancer patients: safety data from the multicentre phase 3 randomised ELDA trial |
scientific article |
Statements
1 reference
Weekly docetaxel versus CMF as adjuvant chemotherapy for elderly breast cancer patients: safety data from the multicentre phase 3 randomised ELDA trial (English)
1 reference
Stefania Gori
1 reference
Maria Carmela Piccirillo
1 reference
Renato Thomas
1 reference
Giuseppe D'Aiuto
1 reference
Vincenzo Labonia
1 reference
Francesco Nuzzo
1 reference
Ermelinda De Maio
1 reference
Adriano Gravina
1 reference
Carmen Pacilio
1 reference
Francesca Di Rella
1 reference
Gabriella Landi
1 reference
Emanuela Rossi
1 reference
Mariantonietta Colozza
1 reference
Sabino De Placido
1 reference
Rossella Lauria
1 reference
Francesco Perrone
1 reference
Andrea de Matteis
1 reference
21 December 2007
1 reference
1 reference
66
1 reference
171-180
1 reference
Identifiers
1 reference
1 reference